Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

How to Manage (Treat) Immediate-type Adverse Reactions to GBCA

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Brain capillary transit time heterogeneity in healthy volunteers measured by dynamic contrast-enhanced T1 -weighted perfusion MRI

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Comparison of global cerebral blood flow measured by phase-contrast mapping MRI with (15) O-H2 O positron emission tomography

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prospective frequency correction for macromolecule-suppressed GABA editing at 3T

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Acute nonrenal adverse reactions to gadolinium-based contrast agents are infrequent and occur often unexpectedly. Most reactions are self-limiting and do not require treatment. The remaining adverse reactions are either moderate or severe and they require medical treatment. Prompt and effective treatment is very important and requires knowledge, training, and preparation.

OriginalsprogEngelsk
TidsskriftJournal of Magnetic Resonance Imaging
Vol/bind25
Udgave nummer6
Sider (fra-til)269-274
Antal sider6
ISSN1053-1807
DOI
StatusUdgivet - dec. 2016

ID: 52653295